PLA2R1 and acute lymphoblastic leukemia: In comparison to the control group, PLA2R1 methylation was approximately nine times higher in the BM of patients at diagnosis of pre-B (71.3% ± 8.6%, p = 0.005) and common ALL (70.7% ± 22.1%, p < 0.001) (Fig. 1A).